Quick Answer
Lexaria Bioscience Corp. reported Research And Development Expense of $8.24 million for the year ending 2025.
- Lexaria Bioscience Corp. showed an increase of +249.0% in Research And Development Expense from 2024 to 2025.
- This data is from Lexaria Bioscience Corp.'s annual report (Form 10-K), filed with the SEC on November 28, 2025.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $8.24 million | Fiscal year 2024: $2.36 million | Fiscal year 2023: $3.67 million | Fiscal year 2022: $1.84 million | Fiscal year 2021: $1.26 million | Fiscal year 2020: $387.1 thousand | Fiscal year 2019: $555.7 thousand | Fiscal year 2018: $492.9 thousand | Fiscal year 2017: $54.2 thousand | Fiscal year 2016: $9.0 thousand | Fiscal year 2015: $146.5 thousand | Fiscal year 2014: $0.00.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: